Arkolith/Insider Trading/ENTO/Form 4

Romano Sarah

Chief Financial OfficerEntero Therapeutics, Inc. (ENTO) · full profile →Form 4 · filed Jul 3, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$664
Net Open-Market Flow
-$664
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 2, 2024Sell(S)621$1.07$66418K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-077714) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML